About Us
R&D
Partners
Media
Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy
JUNE 9 2025
Meet Anodyne at JPM Healthcare Week 2025
JANUARY 12 2025
Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs
DECEMBER 19 2024
Business Wire
Anodyne Presents Successful Preclinical Data of a Once-Weekly GLP-1RA Patch at PODD 2024 in Boston, MA
OCTOBER 25 2024
Anodyne Nanotech, Inc. Appoints Jeff Mihm to its Board of Directors.
FEBRUARY 6 2023